American College of Rheumatology recommendations for the treatment of RA: an issue of choices
Robert BM Landewé Abstract On behalf of the American College of Rheumatology (ACR), Saaget al. recently published recommendations for the use of nonbiologic and biologic DMARDs in rheumatoid arthritis (RA).1 A group of experts was charged with the enormous task of bringing evidence-based clarity to the multitude of treatment options for RA and providing guidance to practicing [...]